LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Pictilisib | 1.11 | uM | LJP6 | 3 | D21 | 72 | hr | 1097 | 1330 | 3769 | 0.3528 | 0.0871 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 1097 | 2915 | 3769 | 0.7733 | 0.6802 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 1097 | 3345 | 3769 | 0.8874 | 0.8411 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 1097 | 3167 | 3769 | 0.8402 | 0.7745 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 1 | O03 | 72 | hr | 1097 | 895 | 3769 | 0.2374 | -0.0757 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 2 | O03 | 72 | hr | 1097 | 1078 | 3769 | 0.2860 | -0.0072 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 3 | O03 | 72 | hr | 1097 | 1086 | 3769 | 0.2881 | -0.0042 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 1 | O03 | 72 | hr | 1097 | 894 | 3769 | 0.2372 | -0.0761 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 2 | O03 | 72 | hr | 1097 | 959 | 3769 | 0.2544 | -0.0517 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 3 | O03 | 72 | hr | 1097 | 1036 | 3769 | 0.2748 | -0.0229 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 1 | E03 | 72 | hr | 1097 | 527 | 3769 | 0.1398 | -0.2134 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 2 | E03 | 72 | hr | 1097 | 589 | 3769 | 0.1563 | -0.1902 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 3 | E03 | 72 | hr | 1097 | 674 | 3769 | 0.1788 | -0.1584 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 1 | C03 | 72 | hr | 1097 | 882 | 3769 | 0.2340 | -0.0806 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 2 | C03 | 72 | hr | 1097 | 716 | 3769 | 0.1899 | -0.1427 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 3 | C03 | 72 | hr | 1097 | 729 | 3769 | 0.1934 | -0.1378 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1097 | 3193 | 3769 | 0.8471 | 0.7843 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1097 | 3408 | 3769 | 0.9041 | 0.8647 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1097 | 3370 | 3769 | 0.8940 | 0.8505 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1097 | 475 | 3769 | 0.1260 | -0.2329 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1097 | 499 | 3769 | 0.1324 | -0.2239 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1097 | 564 | 3769 | 0.1496 | -0.1996 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 1 | F21 | 72 | hr | 1097 | 1905 | 3769 | 0.5054 | 0.3023 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 2 | F21 | 72 | hr | 1097 | 1972 | 3769 | 0.5231 | 0.3273 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 3 | F21 | 72 | hr | 1097 | 2015 | 3769 | 0.5346 | 0.3434 |